Perspectives on Outsourcing

Dec 01, 2003
BioPharm International
Publicly traded CROs and CMOs reported solid financial results in their most recent quarter, but the big news at October's AAPS meeting was the substantial rise in new RFPs and contracts.
Nov 01, 2003
BioPharm International
As FDA tries to bring pharmaceutical manufacturing into the 21st century, changes are likely to favor companies with greater manufacturing expertise and the means to invest in new technoglogies.
Oct 01, 2003
BioPharm International
Outsourcing is in the public eye as politicians debate the lag in job growth despite a recovering economy, and the Bush Administration seeks to ?competitively source? more agency activities.
Sep 01, 2003
BioPharm International
CROs and CMOs have reported on their second quarter financial performance during July and August. Although revenues and profits were up for most companies reporting, the discussions of market conditions surrounding the financial results had a somewhat unsettled feel. Most contractors expect robust revenues in the second half of 2003 but are clearly nervous about whether the activity will actually materialize.
Aug 01, 2003
BioPharm International
BIO 2003 offered many insights into biopharma's future.
Jul 01, 2003
BioPharm International
A Dutch biotech company?s $100 million investment puts the spotlight on biomanufacturing capacity
Apr 15, 2002
BioPharm International
Tough economic times have prompted CROs to reflect on their past performance and to create potential solutions for the future.
Feb 15, 2002
BioPharm International
Not just a quick fix, e-procurement requires a thoughtful and thorough approach to produce the most rewards.
native1_300x100
lorem ipsum